2023 Q2 Form 10-Q Financial Statement

#000079835923000052 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $64.78M $67.90M $60.31M
YoY Change 2.63% 12.57% 29.3%
Cost Of Revenue $27.29M $2.568M $2.253M
YoY Change 903.05% 13.98% 27.5%
Gross Profit $37.48M $65.33M $58.06M
YoY Change -37.94% 12.52% 29.37%
Gross Profit Margin 57.87% 96.22% 96.26%
Selling, General & Admin $4.162M $7.723M $4.500M
YoY Change -20.28% 71.62% 15.09%
% of Gross Profit 11.1% 11.82% 7.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.65M $26.65M $31.10M
YoY Change -1.53% -14.3% 53.6%
% of Gross Profit 65.75% 40.79% 53.56%
Operating Expenses $28.53M $33.72M $35.50M
YoY Change -4.86% -5.03% 48.54%
Operating Profit $8.950M $62.60M -$3.911M
YoY Change 133.38% -1700.54% -338.33%
Interest Expense -$8.346M $10.32M $7.715M
YoY Change -210.38% 33.75% 6.69%
% of Operating Profit -93.25% 16.48%
Other Income/Expense, Net
YoY Change
Pretax Income -$2.380M $52.33M -$10.56M
YoY Change -36.41% -595.38% 104.71%
Income Tax
% Of Pretax Income
Net Earnings -$3.470M $43.57M -$8.589M
YoY Change 16.01% -607.29% 76.47%
Net Earnings / Revenue -5.36% 64.17% -14.24%
Basic Earnings Per Share -$0.23 $2.79 -$0.68
Diluted Earnings Per Share -$0.23 $2.76 -$0.68
COMMON SHARES
Basic Shares Outstanding 14.96M shares 15.03M shares 15.10M shares
Diluted Shares Outstanding 14.95M shares 18.36M shares 15.10M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.745M $8.939M $13.31M
YoY Change -25.93% -32.86% 23.09%
Cash & Equivalents $9.745M $8.939M $13.31M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.745M $8.939M $13.31M
YoY Change -25.93% -32.86% 23.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.891B $1.902B $1.925B
YoY Change -1.19% -1.22% 27.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $566.0K $48.90M $2.409M
YoY Change -70.43% 1930.01% 50.56%
Total Long-Term Assets $1.910B $1.970B $1.952B
YoY Change -1.24% 0.91% 27.97%
TOTAL ASSETS
Total Short-Term Assets $9.745M $8.939M $13.31M
Total Long-Term Assets $1.910B $1.970B $1.952B
Total Assets $1.920B $1.979B $1.966B
YoY Change -1.41% 0.68% 27.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.71M $56.64M $50.36M
YoY Change 17.96% 12.47% -6.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $56.71M $56.64M $50.36M
YoY Change 17.96% 12.47% -6.57%
LONG-TERM LIABILITIES
Long-Term Debt $881.5M $917.9M $866.9M
YoY Change 1.29% 5.88% 9.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $881.5M $917.9M $866.9M
YoY Change 1.29% 5.88% 9.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.71M $56.64M $50.36M
Total Long-Term Liabilities $881.5M $917.9M $866.9M
Total Liabilities $1.165B $974.5M $917.3M
YoY Change 26.87% 6.24% 8.12%
SHAREHOLDERS EQUITY
Retained Earnings -$522.8M -$508.4M -$495.7M
YoY Change 2.2% 2.56% 11.8%
Common Stock $1.170B $1.176B $1.204B
YoY Change -3.17% -2.3% 22.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $755.0M $759.3M $798.9M
YoY Change
Total Liabilities & Shareholders Equity $1.920B $1.979B $1.966B
YoY Change -1.41% 0.68% 27.94%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.470M $43.57M -$8.589M
YoY Change 16.01% -607.29% 76.47%
Depreciation, Depletion And Amortization $24.65M $26.65M $31.10M
YoY Change -1.53% -14.3% 53.6%
Cash From Operating Activities $23.76M $21.80M $11.60M
YoY Change 3.77% 88.0% -22.45%
INVESTING ACTIVITIES
Capital Expenditures $13.84M $11.24M -$13.02M
YoY Change -232.11% -186.31% -83.69%
Acquisitions
YoY Change
Other Investing Activities -$103.0K -$834.0K -$288.0K
YoY Change -70.06% 189.58% 80.0%
Cash From Investing Activities -$13.94M $131.2M -$12.73M
YoY Change 28.86% -1130.43% -85.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $31.68M
YoY Change 168.92%
Debt Paid & Issued, Net $20.73M
YoY Change
Cash From Financing Activities -57.35M -$107.0M -$21.77M
YoY Change 350.55% 391.67% -128.95%
NET CHANGE
Cash From Operating Activities 23.76M $21.80M $11.60M
Cash From Investing Activities -13.94M $131.2M -$12.73M
Cash From Financing Activities -57.35M -$107.0M -$21.77M
Net Change In Cash -47.53M $45.95M -$22.90M
YoY Change 7190.03% -300.63% -547.67%
FREE CASH FLOW
Cash From Operating Activities $23.76M $21.80M $11.60M
Capital Expenditures $13.84M $11.24M -$13.02M
Free Cash Flow $9.922M $10.57M $24.62M
YoY Change -70.26% -57.07% -74.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000798359
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35624
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CENTERSPACE
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
ND
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0311232
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3100 10th Street SW
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Post Office Box 1988
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Minot
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ND
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
58702-1988
CY2023Q1 dei City Area Code
CityAreaCode
701
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
837-4738
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14960425 shares
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2420911000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2534124000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
519167000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
535401000 usd
CY2023Q1 us-gaap Investments
Investments
1901744000 usd
CY2022Q4 us-gaap Investments
Investments
1998723000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8939000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10458000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
48903000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1433000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
19298000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
22687000 usd
CY2023Q1 us-gaap Assets
Assets
1978884000 usd
CY2022Q4 us-gaap Assets
Assets
2033301000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
56639000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
58812000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
143469000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
113500000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
299412000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
399007000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
474999000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
495126000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
974519000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1066445000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
100
CY2023Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
100
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
166000 shares
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
166000 shares
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
166000 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
166000 shares
CY2022Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
16560000 usd
CY2023Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
16560000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
16560000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
16560000 usd
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
25
CY2023Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
25
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3881000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3881000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3881000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3881000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
729537000 usd
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
97036000 usd
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
97036000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
93530000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
93530000 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15032000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15032000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15020000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15020000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1176059000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1177484000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-508420000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-539422000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1917000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2055000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
759252000 usd
CY2023Q1 csr Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders
NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders
227920000 usd
CY2022Q4 csr Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders
NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders
220132000 usd
CY2023Q1 us-gaap Other Minority Interests
OtherMinorityInterests
633000 usd
CY2022Q4 us-gaap Other Minority Interests
OtherMinorityInterests
627000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
987805000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
950296000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1978884000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2033301000 usd
CY2023Q1 us-gaap Revenues
Revenues
67897000 usd
CY2022Q1 us-gaap Revenues
Revenues
60314000 usd
CY2023Q1 csr Property Operating Expenses Excluding Real Estate Taxes
PropertyOperatingExpensesExcludingRealEstateTaxes
21342000 usd
CY2022Q1 csr Property Operating Expenses Excluding Real Estate Taxes
PropertyOperatingExpensesExcludingRealEstateTaxes
19014000 usd
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
7581000 usd
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
6859000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2568000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2253000 usd
CY2023Q1 csr Insurance Gain Loss Casualty
InsuranceGainLossCasualty
-252000 usd
CY2022Q1 csr Insurance Gain Loss Casualty
InsuranceGainLossCasualty
-598000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25993000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31001000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7723000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4500000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
65459000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
64225000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
60159000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
62597000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3911000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
10319000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
7715000 usd
CY2023Q1 csr Interest And Other Income Loss
InterestAndOtherIncomeLoss
49000 usd
CY2022Q1 csr Interest And Other Income Loss
InterestAndOtherIncomeLoss
1063000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
52327000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-10563000 usd
CY2023Q1 csr Preferred Stock Dividends
PreferredStockDividends
160000 usd
CY2022Q1 csr Preferred Stock Dividends
PreferredStockDividends
160000 usd
CY2023Q1 csr Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable
8566000 usd
CY2022Q1 csr Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable
-2157000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable
30000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable
23000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
43571000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8589000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1607000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1607000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
41964000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10196000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.79
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.76
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2023Q1 us-gaap Profit Loss
ProfitLoss
52327000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-10563000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1581000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-138000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-304000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52465000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8678000 usd
CY2023Q1 csr Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders
ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders
8543000 usd
CY2022Q1 csr Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders
ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders
-2480000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable
30000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable
23000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43892000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6221000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
996280000 usd
CY2022Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-10723000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1885000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.73
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
11946000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
719000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
31684000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
22882000 usd
CY2022Q1 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
0 usd
CY2022Q1 csr Partners Capital Account Cash Redemptions
PartnersCapitalAccountCashRedemptions
2903000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1274000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
253000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1025906000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
950296000 usd
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
52167000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
138000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.73
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
11668000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1519000 usd
CY2023Q1 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
0 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1022000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
161000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
153000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
987805000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
52327000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-10563000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26650000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31096000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
60159000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1519000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
719000 usd
CY2023Q1 csr Gain Loss On Interest Rate Swap Mark To Market And Settlement Amortization
GainLossOnInterestRateSwapMarkToMarketAndSettlementAmortization
-138000 usd
CY2022Q1 csr Gain Loss On Interest Rate Swap Mark To Market And Settlement Amortization
GainLossOnInterestRateSwapMarkToMarketAndSettlementAmortization
613000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-194000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-416000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1783000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1316000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-648000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10773000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21804000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11598000 usd
CY2023Q1 csr Proceeds From Sale Of Real Estate And Other Investments
ProceedsFromSaleOfRealEstateAndOtherInvestments
141587000 usd
CY2022Q1 csr Proceeds From Sale Of Real Estate And Other Investments
ProceedsFromSaleOfRealEstateAndOtherInvestments
0 usd
CY2023Q1 us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
9545000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
11237000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
3474000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-834000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-288000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
131184000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12731000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20734000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2154000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
35969000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6000000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
43000000 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
100000000 usd
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
CY2022Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
3209000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31684000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1022000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
2903000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10917000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10812000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1607000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1607000 usd
CY2023Q1 csr Payments Of Ordinary Dividends Preferred Unitholders
PaymentsOfOrdinaryDividendsPreferredUnitholders
160000 usd
CY2022Q1 csr Payments Of Ordinary Dividends Preferred Unitholders
PaymentsOfOrdinaryDividendsPreferredUnitholders
160000 usd
CY2023Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
2413000 usd
CY2022Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
2356000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-153000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-253000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-107037000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21770000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45951000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22903000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11891000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38625000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57842000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15722000 usd
CY2023Q1 csr Adjustments To Accounts Payable Included Within Real Estate Investments
AdjustmentsToAccountsPayableIncludedWithinRealEstateInvestments
3804000 usd
CY2022Q1 csr Adjustments To Accounts Payable Included Within Real Estate Investments
AdjustmentsToAccountsPayableIncludedWithinRealEstateInvestments
2596000 usd
CY2023Q1 csr Conversion Of Stock Amount Converted Net
ConversionOfStockAmountConvertedNet
-697000 usd
CY2022Q1 csr Conversion Of Stock Amount Converted Net
ConversionOfStockAmountConvertedNet
-388000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11668000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11946000 usd
CY2023Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
935000 usd
CY2022Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
CY2023Q1 csr Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes
NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes
161000 usd
CY2022Q1 csr Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes
NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes
1274000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
41623000 usd
CY2023Q1 csr Fair Value Adjustment Debt
FairValueAdjustmentDebt
0 usd
CY2022Q1 csr Fair Value Adjustment Debt
FairValueAdjustmentDebt
1224000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
43276000 usd
CY2023Q1 csr Noncashor Part Noncash Acquisition Write Off Of Receivable In Exchange For Property
NoncashorPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty
0 usd
CY2022Q1 csr Noncashor Part Noncash Acquisition Write Off Of Receivable In Exchange For Property
NoncashorPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty
43276000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6168000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7182000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8939000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10458000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13313000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
48903000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1433000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2409000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57842000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11891000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15722000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1607000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
RECLASSIFICATIONSCertain previously reported amounts in Note 9 have been reclassified to conform to the current financial statement presentation. These reclassifications had no impact on net income as reported in the Condensed Consolidated Statement of Operations, total assets, liabilities or equity as reported in the Condensed Consolidated Balance Sheets and total shareholder’s equity.
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1607000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
41964000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
2281000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
2999000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
2953000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
2350000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
1265000 usd
CY2023Q1 csr Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
5760000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
17608000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10196000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
-8566000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
63265000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
56673000 usd
CY2023Q1 us-gaap Variable Lease Income
VariableLeaseIncome
3500000 usd
CY2022Q1 us-gaap Variable Lease Income
VariableLeaseIncome
2523000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1132000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1118000 usd
CY2023Q1 us-gaap Revenues
Revenues
67897000 usd
CY2022Q1 us-gaap Revenues
Revenues
60314000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
60200000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET CONCENTRATION RISK</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to increased exposure from economic and other competitive factors specific to markets where we hold a significant percentage of the carrying value of our real estate portfolio. As of March 31, 2023, we held more than 10% of the carrying value of our real estate portfolio in each of the following markets: Minneapolis, Minnesota and Denver, Colorado.</span></div>
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable
2157000 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
702000 usd
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
676000 usd
CY2023Q1 csr Ratio Of Units Exchanged For Shares
RatioOfUnitsExchangedForShares
1
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
43571000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8589000 usd
CY2023Q1 csr Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount
PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount
160000 usd
CY2022Q1 csr Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount
PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount
160000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
50690000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12193000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15025000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15097000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
968000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 csr Incremental Common Shares Attributable To Conversion Of Restricted Stock
IncrementalCommonSharesAttributableToConversionOfRestrictedStock
20000 shares
CY2022Q1 csr Incremental Common Shares Attributable To Conversion Of Restricted Stock
IncrementalCommonSharesAttributableToConversionOfRestrictedStock
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18359000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15097000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.79
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.76
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2023Q1 csr Noncontrolling Interests In Operating Partnership Units Outstanding
NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding
967000 shares
CY2022Q4 csr Noncontrolling Interests In Operating Partnership Units Outstanding
NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding
971000 shares
CY2022Q1 csr Noncontrolling Interest In Operating Partnership Units Issued
NoncontrollingInterestInOperatingPartnershipUnitsIssued
209000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15000000 shares
CY2022Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
338000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
19900000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
19464 shares
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1022000 usd
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
52.51
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
921659000 usd
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0371
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1011777000 usd
CY2022Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0362
CY2023Q1 csr Debt Instrument Weighted Average Maturity
DebtInstrumentWeightedAverageMaturity
P6Y21D
CY2023Q1 csr Number Of Real Estate Properties Unencumbered
NumberOfRealEstatePropertiesUnencumbered
50 apartmentcommunity
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
25995000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8981000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
173350000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
50088000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
47088000 usd
CY2023Q1 csr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
616157000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
921659000 usd
CY2023Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
995000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
844000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8300000 usd
CY2023Q1 csr Number Of Exchange Transactions
NumberOfExchangeTransactions
4 transaction
CY2023Q1 us-gaap Revenues
Revenues
67897000 usd
CY2023Q1 csr Property Operating Expense
PropertyOperatingExpense
28923000 usd
CY2023Q1 csr Net Operating Income Loss
NetOperatingIncomeLoss
38974000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2568000 usd
CY2023Q1 csr Insurance Gain Loss Casualty
InsuranceGainLossCasualty
-252000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25993000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7723000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
60159000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
10319000 usd
CY2023Q1 csr Interest And Other Income Loss
InterestAndOtherIncomeLoss
49000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
52327000 usd
CY2022Q1 us-gaap Revenues
Revenues
60314000 usd
CY2022Q1 csr Property Operating Expense
PropertyOperatingExpense
25873000 usd
CY2022Q1 csr Net Operating Income Loss
NetOperatingIncomeLoss
34441000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2253000 usd
CY2022Q1 csr Insurance Gain Loss Casualty
InsuranceGainLossCasualty
-598000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31001000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4500000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
7715000 usd
CY2022Q1 csr Interest And Other Income Loss
InterestAndOtherIncomeLoss
1063000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-10563000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2420911000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
519167000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1901744000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8939000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
48903000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
19298000 usd
CY2023Q1 us-gaap Assets
Assets
1978884000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2534124000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
535401000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1998723000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10458000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1433000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
22687000 usd
CY2022Q4 us-gaap Assets
Assets
2033301000 usd
CY2023Q1 csr Number Of Real Estate Technology Venture Funds With Unfunded Commitments
NumberOfRealEstateTechnologyVentureFundsWithUnfundedCommitments
2 realestatetechnologyventurefund
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
775000 shares
CY2015Q3 csr Share Based Compensation Arrangement By Share Based Payment Award Term Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward
P10Y
CY2023Q1 csr Share Based Compensation Arrangement By Share Based Payment Award Term Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward
P3Y
CY2023Q1 us-gaap Share Price
SharePrice
58.67
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
719000 usd

Files In Submission

Name View Source Status
csr-20230331_def.xml Edgar Link unprocessable
csr-20230331_cal.xml Edgar Link unprocessable
0000798359-23-000052-index-headers.html Edgar Link pending
0000798359-23-000052-index.html Edgar Link pending
0000798359-23-000052.txt Edgar Link pending
0000798359-23-000052-xbrl.zip Edgar Link pending
centerspace033123-10qex311.htm Edgar Link pending
centerspace033123-10qex312.htm Edgar Link pending
centerspace033123-10qex321.htm Edgar Link pending
centerspace033123-10qex322.htm Edgar Link pending
csr-20230331.htm Edgar Link pending
csr-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
csr-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
csr-20230331_pre.xml Edgar Link unprocessable
csr-20230331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending